Science Letters：IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1

Insulin-like growth factor binding-protein-7 （IGFBP7） was obtained from our previous colonic adenocarcinoma （CRC） and normal mucosa suppression subtraction hybridization （SSH） cDNA libraries. By RT-PCR and immunohistochemistry, we found that IGFBP7 was overexpressed in CRC tissue compared to normal tissue. However, our in vitro experiments performed in 10 CRC cell lines showed that IGFBP7 expressed only in SW480 and Caco2 cell lines, which implied an underlying reversible regulatory mechanism. Using methylation-specific PCR （MSP） and bisulfite sodium PCR （BSP）, we found that its expression was associated with DNA hypomethylation of exonl. This was further supported by the in vitro study which showed restored IGFBP7 expression after demethylation agent 5-aza-2＇-deoxycytidine treatment. Correlation analysis between IGFBP7 expression and prognosis indicated that overexpression of IGFBP7 in CRC tissue correlated with favourable survival. Investigation of the functional role of IGFBP7 through transfection studies showed that IGFBP7 protein could inhibit growth rate, decrease colony formation activity, and induce apoptosis in RKO and SW620 cells, suggesting it a potential tumor suppressor protein in colorectal carcinogenesis. In conclusion, our study clearly demonstrated that IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis and its expression is associated with DNA hypomethylation of exon 1.     

美国重要癌症基金资助现状分析

本文综合美国主要癌症基金过去7年中对癌症项目的资助情况,从项目的领域分布、项目的数量变化、项目的类型分布、癌症种类情况等多个角度,分析美国癌症基金的资助现状和特点,对了解和把握国外癌症研究方向有借鉴意义,同时为我国癌症基金工作提供有益思路。     

双歧杆菌介导的福氏志贺菌Bb-ipaB疫苗的构建

目的：构建福氏志贺菌重组双歧杆菌Bb-ipaB疫苗。方法：以福氏志贺菌DNA为模板扩增福氏志贺菌ipaB基因,双酶切后克隆到pGEX-1λT质粒上,构建重组质粒pGEX-ipaB,电穿孔法将该质粒转化入Bb,构建福氏志贺菌重组Bb-ipaB疫苗。结果：成功扩增出分子量约为1 711 bp的ipaB基因,双酶切证实基因成功插入pGEX-1λT中,并成功转化入双歧杆菌,构建rBb-ipaB疫苗。结论：成功构建福氏志贺菌重组rBb-ipaB疫苗,为该疫苗的进一步研究奠定了基础。     

自由基与肺癌发病机制

肺癌是严重影响人类健康的疾病,其发病机制目前尚未阐明.自由基医学是近年来兴起的一门交叉学科,本文对自由基在吸烟、职业烟尘微粒、金属离子、石英、石棉等理化因素致肺癌过程中的发病机制进行探讨.     

子宫颈癌疫苗研究新进展

子宫颈癌是妇女中最常见的恶性肿瘤之一。人乳头状瘤病毒感染是子宫颈癌发生的基本因素,预防人乳头状瘤病毒感染就可以避免子宫颈癌的发生,理想的预防方法是应用人乳头状瘤病毒疫苗。目前预防和治疗宫颈癌的疫苗类型有载体类、抗原相关类、细胞类等。本文综述了上述疫苗的作用机理及研究进展。并对未来宫颈癌的治疗进行了展望。     

光敏疗法治疗口腔癌15例报告

应用光敏疗法治疗口腔癌１５例，其中ＣＲ１例，ＰＲ８例，ＭＲ４例，ＮＲ２例，总有效率为６０％（ＣＲ＋ＰＲ），观察表明对浅表肿瘤疗效较好     

两种计划免疫苗种需求预测模型

全文分两部分,第一部分指出计划免疫苗种需求与总和生育率及生育模式的直接关系,应用一种婴儿出生数计算式及胎次率人口系统模型,提出一种苗种需求模型;第二部分利用数方法,提出一种比较实用的苗种需求模型。     

CD44v6mRNA和HSP70mRNA在胃癌中的表达及研究

目的:检测CD44v6mRNA和HSP70mRNA在胃癌组织中的表达,探讨CD44v6mRNA和HSP70mRNA在胃癌发生发展中的作用.方法:利用核酸原位杂交技术对39例胃癌组织进行检测.结果:CD44v6mRNA和HSP70mRNA在胃癌组织表达的阳性率都为61.54%(24/39),CD44v6mRNA和HSP70mRNA在高分化管状腺癌与低分化管状腺癌中的表达都有显著性差异(P＜0.05),但HSP70mRNA在胃癌组织的表达与性别、年龄、浸润深度及淋巴结有无转移都无关(P＞0.05),而CD44v6mRNA与淋巴结有无转移有关(P＜0.05).结论:CD44v6mRNA和HSP70mRNA在胃癌组织都有较高的表达,两者均可作为评估胃癌预后的指标.     

Session - 3 December 19, 2007 Cardiovascular risk markers - II

Oral Cancer is one of the five leading sites of cancer in Indian population. The circulating immune complexes were investigated in 100 serum samples of 60 oral cancer patients having different grades of the disease and 40 patients with precancerous lesions obtained from Nair Hospital Dental collage, Mumbai. The results obtained were compared with those of group of 40 healthy blood donors. Elevated levels of Circulating Immune Complexes were observed in oral cancer patients and patients with oral precancerous lesions. 92% positive samples were observed in well differentiated squamous cell carcinoma whereas 100% positive samples were observed in both moderately and poorly differentiated squamous cell carcinoma. Oral leukoplakia and oral submucous fibrosis showed 15% and 90% positivity respectively. Increased level of Circulating Immune complexes in high grade tumor suggest that Circulating Immune complexes is likely to contribute in evaluating the degree of malignancy, but follow up study is needed to draw any conclusion regarding it's prognostic role     

乳腺癌耐受蛋白介导5-氟脲嘧啶的耐受及机制探讨

AIM To filtrate breast cancer resistance protein(BCRP)-mediated resistance agents and investigate the mechanism,so as to provide valuable datum for optimization clinical chemotherapy scheme to tumor with evaluation marker of BCRP expression. METHODS MTT assay was used to filtrate BCRP-mediated resistance agents with PA317/Tet-on/TRE-BCRP cell of different expression levels of BCRP after treated with different concentration anticancer agents. High performance liquid chromatography(HPLC) was applied to measure relative dose of intracellular retention resistance agents. Nuclear DNA fluorescence dye,Hochest 33258, staining and flow cytometry were adopted to detect apoptotic cells after treated with drugs. RESULTS There were shown increasing durg-resistance to 5-fluorouracil,methotrexate, doxirubicin, pirarubicin,etoposide and mitoxantrone followed with increasing expression of BCRP on PA317/Tet-on/TRE-BCRP cells(P＜0.05, n=3),but shown sensitive to paclitaxel, cisplatin, vincristine, mitomycin and vindesine. There also was shown significant negative correlation between the intracellular retention dose of 5-fluorouracil with different expression of BCRP(r=-0.885, P＜0.05, n=3).There were shown parallel results of that decreasing cellular apoptotic rate with increasing cellular expression of BCRP after treated with 5-fluorouracil by fluorescence dye staining and flow cytometry(P＜0.05, n=3),and also shown significate rise of the apoptotic rate of BCRP expression cells after treated with Ko143 (P＜0.05, n=3). Every group of cells could be different extently blocked in phase of G0/G1 treated with 5-fluorouracil. CONCLUSION Resistance of 5-fluorouracil could be especially mediated by conjugated with BCRP and acted as drug exclude-pump substrate. Cellular ability resistant to 5-fluorouracil-induced apoptosis could be reinforced by BCRP expression.